Evidence map›Paper›PMID 32424899›Full record

ArticleAllergy2020

Real-life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREA.

Sven F Seys, Shana De Bont, Wytske J Fokkens, Claus Bachert, Isam Alobid, Manuel Bernal-Sprekelsen, Leif Bjermer, Ina Callebaut, Lars-Olaf Cardell, Sean Carrie and 51 more

Open access · hybridAbstract read
In one paragraph

Article in Allergy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Heterogeneity in the definition of chronic rhinosinusitis disease control: a systematic review of the scientific literature.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Estimation of the indirect costs associated with chronic rhinosinusitis with nasal polyposis in Spain: an analysis from a societal perspective.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Observational
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. [LASSO regression based risk prediction model for postoperative control in chronic sinusitis with nasal polyps].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2024
    Article
  16. Effects of Endoscopic Sinus Surgery on Olfactory Function.Current allergy and asthma reports · 2023
    Review
  17. Article
  18. The "real life" efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP.Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale · 2023
    Article
  19. [A prospective study of the effect of functional endoscopic sinus surgery on the recovery of olfactory function in patients with chronic rhinosinusitis with nasal polyposis].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

61 authors at 20 institutions in 16 countries.

Sven F SeysEuropean Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium.ORCID 0000-0002-4399-9892
Shana De BontDepartment of Otorhinolaryngology-Head and Neck Surgery, UZ Leuven, UZ Leuven, Belgium.
Wytske J FokkensDepartment of Otorhinolaryngology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.ORCID 0000-0003-4852-229X
Claus BachertUpper Airways Research Laboratory, Department of Otorhinolaryngology, Ghent University, Belgium.ORCID 0000-0003-4742-1665
Isam AlobidHospital Clínic, IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Spain.
Manuel Bernal-SprekelsenUniversity of Valencia, Valencia, Spain.
Leif BjermerDepartment of Respiratory Medicine and Allergology, Lund University, Lund, Sweden.
Ina CallebautDepartment of Otorhinolaryngology-Head and Neck Surgery, UZ Leuven, UZ Leuven, Belgium.
Lars-Olaf CardellDivision of ENT Diseases, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-0538-9580
Sean CarrieENT department, Freeman Hospital, Newcastle upon Tyne, UK.
Paolo CastelnuovoENT Department, University of Insubria, Ospedale Di Circolo E Fondazione Macchi, Varese, Italy.
Russell CathcartENT department, Cumberland Infirmary, Carlisle, UK.
Jannis Constantinidis1st Academic ENT Department, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece.
Leen CoolsDepartment of Otorhinolaryngology-Head and Neck Surgery, UZ Leuven, UZ Leuven, Belgium.
Marjolein CornetDepartment of Otorhinolaryngology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Gregory ClementENT department, AZ Damiaan, Oostende, Belgium.
Tony CoxENT department, Jessa hospital, Hasselt, Belgium.
Lieve DelsupeheENT department, AZ Delta, Roeselare, Belgium.
Jaime Correia-de-SousaLife and Health Sciences Research Institute (ICVS)/3B's-PT Government Associate Laboratory, University of Minho, Braga, Portugal.ORCID 0000-0001-6459-7908
Lauren DeneyerEuropean Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium.
Geert De VosENT department, Sint-Lucas, Gent, Belgium.
Zuzana DiamantDepartment of Respiratory Medicine and Allergology, Lund University, Lund, Sweden.
Maria DoulaptsiDepartment of Otorhinolaryngology-Head and Neck Surgery, University of Crete School of Medicine, Heraklion, Greece.ORCID 0000-0001-9011-0315
Simon GaneENT Department, Royal National Throat Nose and Ear Hospital, London, UK.
Philippe GevaertUpper Airways Research Laboratory, Department of Otorhinolaryngology, Ghent University, Belgium.
Claire HopkinsENT Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Valérie HoxDépartement d'Otorhinolaryngologie, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Thomas HummelSmell and Taste Clinic, ENT department, Technische Universität Dresden, Dresden, Germany.
Werner HosemannDepartment of Otorhinolaryngology, Head and Neck Surgery, University of Greifswald, Germany.
Raf JacobsDepartment of Otorhinolaryngology-Head and Neck Surgery, General Hospital Sint-Blasius, Dendermonde, Belgium.
Mark JorissenDepartment of Otorhinolaryngology-Head and Neck Surgery, UZ Leuven, UZ Leuven, Belgium.
Anette KjeldsenDepartment of Otorhinolaryngology, Odense University Hospital, Odense, Denmark.
Basile N LandisUnité de Rhinologie-Olfactologie, Service d'Oto-Rhino-Laryngologie et de Chirurgie cervico-faciale, Hôpitaux Universitaires de Genève, Genève, Suisse.
Winde LemmensENT department, ZOL Genk, Genk, Belgium.
Andreas LeunigENT department, Ludwig Maximilians University Munich, Germany.
Valerie LundENT Department, Royal National Throat Nose and Ear Hospital, London, UK.
Gert MariënEuropean Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium.
Joaquim MullolHospital Clínic, IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Spain.
Metin OnerciENT Department, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Susanna PalkonenEuropean Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium.
Isabel ProanoEuropean Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium.
Emmanuel ProkopakisDepartment of Otorhinolaryngology-Head and Neck Surgery, University of Crete School of Medicine, Heraklion, Greece.
Dermot RyanUsher Institute, University of Edinburgh, UK.ORCID 0000-0002-4115-7376
Herbert RiechelmannUniversitätsklinik für Hals- Nasen- Ohrenheilkunde Innsbruck, Austria.
Pernilla Sahlstrand-JohnsonDepartment of Oto-Rhino-Laryngology, Head and Neck Surgery, Lund University, Skane University Hospital, Lund, Sweden.
Sanna Salmi-ToppilaSkin and Allergy Hospital, Helsinki University Central Hospital, Helsinki, Finland.ORCID 0000-0003-0890-6686
Christine SegboerDepartment of Otorhinolaryngology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Kato SpelemanENT Department, AZ Sint-Jan, Bruges, Belgium.
Andreas SteinsvikDepartment of Otorhinolaryngology, Akershus University Hospital, Lørenskog, Norway.
Pavol SurdaENT Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID 0000-0003-1453-0179
Peter-Valentin TomazicDepartment of General ORL, Head and Neck Surgery, Medical University of Graz, Graz, Austria.ORCID 0000-0001-6445-4800
Olivier VandervekenENT department, University Hospital of Antwerp, Wilrijk, Belgium.
Laura Van GervenDepartment of Otorhinolaryngology-Head and Neck Surgery, UZ Leuven, UZ Leuven, Belgium.
Thibaut Van ZeleUpper Airways Research Laboratory, Department of Otorhinolaryngology, Ghent University, Belgium.
Jan VerfaillieENT department, AZ Delta, Roeselare, Belgium.
Benedicte VerhaegheENT department, Sint-Andriesziekenhuis, Tielt, Belgium.
Kathie VierstraeteENT department, AZ Groeninge, Kortrijk, Belgium.
Stephan VlaminckENT department, CHM Mouscron, Mouscron, Belgium.
Martin WagenmannDepartment of Otorhinolaryngology, Universitätsklinikum Düsseldorf, Dusseldorf, Germany.
Benoit PuginEuropean Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium.
Peter W HellingsDepartment of Microbiology, Immunology & Transplantation, Allergy and Clinical Immunology Research Group, KU Leuven, Belgium.
Universitair Ziekenhuis Leuven · BEAmsterdam University Medical Centers · NLLund University · SEAZ Delta · BECentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESEuropean Federation of Allergy and Airways Diseases Patients Associations · BEGhent University · BEGuy's and St Thomas' NHS Foundation Trust · GBKarolinska Institutet · SEKU Leuven · BERoyal National Throat Nose and Ear Hospital · GBUniversity of Crete · GRAkershus University Hospital · NOAntwerp University Hospital · BEAristotle University of Thessaloniki · GRAZ Groeninge · BEAZ Sint-Blasius · BEAZ Sint-Jan · BEAZ Sint-Lucas · BECentre Hospitalier de Mouscron · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic rhinosinusitis (CRS) is a chronic inflammatory disease associated with a substantial personal and socioeconomic burden. Monitoring of patient-reported outcomes by mobile technology offers the possibility to better understand real-life burden of CRS.

methodsThis study reports on the cross-sectional evaluation of data of 626 users of mySinusitisCoach (mSC), a mobile application for CRS patients. Patient characteristics of mSC users were analysed as well as the level of disease control based on VAS global rhinosinusitis symptom score and adapted EPOS criteria.

resultsThe mSC cohort represents a heterogeneous group of CRS patients with a diverse pattern of major symptoms. Approximately half of patients reported nasal polyps. 47.3% of all CRS patients were uncontrolled based on evaluation of VAS global rhinosinusitis symptom score compared to 40.9% based on adapted EPOS criteria. The impact of CRS on sleep quality and daily life activities was significantly higher in uncontrolled versus well-controlled patients. Half of patients had a history of FESS (functional endoscopic sinus surgery) and reported lower symptom severity compared to patients without a history of FESS, except for patients with a history of more than 3 procedures. Patients with a history of FESS reported higher VAS levels for impaired smell.

conclusionReal-life data confirm the high disease burden in uncontrolled CRS patients, clearly impacting quality of life. Sinus surgery improves patient-reported outcomes, but not in patients with a history of more than 3 procedures. Mobile technology opens a new era of real-life monitoring, supporting the evolution of care towards precision medicine.

Indexed as

Nasal PolypsRhinitisSinusitisChronic DiseaseCross-Sectional StudiesHumansQuality of LifeMobile health technologynasal polyppatient-reported outcome measurereal-world evidencevisual analogue scale

Identifiers

PMID32424899
PMCPMC7687134
OpenAlexW3026800020

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.